Futures in Biotech

On the latest episode (#14, posted on 3/23/07) of Futures in Biotech, host Marc Pelletier talks with the founder and scientists from the Myelin Repair Foundation. The MRF is pioneering a new collaborative form of research aimed at developing treatments for multiple sclerosis, which is a disease where the myelin insulation of neurons is destroyed in an intermittent and unpredictable manner.

As of March 24, there are no show notes on the website, but I will mention that although this podcast appears fairly irregularly, it often has interviews with leading edge scientists in the biotech field. One of my favorite interviews was episode 10 with Harvard neurobiologist, Dr. Carla Shatz.